Antiviral therapy for COVID-2019
The whole world is experiencing a global pandemic caused by Coronavirus disease 2019. As the pandemic progresses, there has been much research on antiviral drugs, such as hydroxychloroquin, chloroquine, remdesivir, lopinavir-ritonavir, favipiravir, oseltamivir, and umifenovir. Specific antiviral dr...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Article PeerReviewed |
| 語言: | English English English English |
| 出版: |
Faculty of Anaesthesia, AFMS
2021
|
| 主題: | |
| 在線閱讀: | https://repository.unair.ac.id/117645/1/C-3%20Peer%20Review.pdf https://repository.unair.ac.id/117645/2/C-3%20Turnitin.pdf https://repository.unair.ac.id/117645/3/C-3%20Artikel.pdf https://repository.unair.ac.id/117645/4/C-3%20Bukti%20Koresponding.pdf https://repository.unair.ac.id/117645/ https://www.apicareonline.com/index.php/APIC/article/view/1522 https://doi.org/10.35975/apic.v25i3.1522 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 總結: | The whole world is experiencing a global pandemic caused by Coronavirus disease 2019. As the pandemic progresses, there has been much research on antiviral drugs, such as hydroxychloroquin, chloroquine, remdesivir, lopinavir-ritonavir, favipiravir, oseltamivir, and umifenovir. Specific antiviral drugs proven to be effective against SARS-CoV-2 have not been found and approved for the medication of COVID-19. Currently, case detection, infection control, monitoring, prevention, and supportive care are the means focused on the treatment of COVID-19. A large scale research is currently underway to analyze safety and efficacy of antiviral drugs, while trials of the SAR-CoV-2 vaccine are rapidly expanding. This mini review briefly introduces the current antiviral therapy for COVID-19. |
|---|